<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-DOP-1890</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-1890</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Зависимость фенотипа и хемилюминесцентной активности моноцитов от количества Т-регуляторных клеток у больных раком почки</article-title><trans-title-group xml:lang="en"><trans-title>Dependence of phenotype and chemiluminescent activity of monocytes on the Tregulatory cells content in patients with kidney cancer</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Савченко</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Savchenko</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Савченко Андрей Анатольевич — докторр медицинских наук, профессор, руководитель лаборатории клеточно-молекулярной физиологии и патологии.</p><p>Красноярск</p></bio><bio xml:lang="en"><p>Savchenko Andrei Anatyevich - PhD, MD (Medicine), Professor, Head, Laboratory of Molecular and Cellular Physiology and Pathology.</p><p>Krasnoyarsk</p></bio><email xlink:type="simple">aasavchenko@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Борисов</surname><given-names>А. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Borisov</surname><given-names>A. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Борисов Александр Геннадьевич — кандидат медицинских наук, ведущий научный сотрудник лаборатории клеточно-молекулярной физиологии и патологии.</p><p>Красноярск</p></bio><bio xml:lang="en"><p>Borisov Alexandr Gennadyevich - PhD (Medicine), Leading Research Associate, Laboratory of Molecular and Cellular Physiology and Pathology.</p><p>Krasnoyarsk</p></bio><email xlink:type="simple">2410454@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кудрявцев</surname><given-names>И. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kudryavtsev</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кудрявцев Игорь Владимирович — кандидат биологических наук, старший научный сотрудник отдела иммунологии ИЭМ; доцент кафедры иммунологии Первый Санкт-Петербургский ГМУ им. академика И.П. Павлова.</p><p>197376, Санкт-Петербург, ул. Акад. Павлова, 12, Тел.: 8 (812) 234-16-69</p></bio><bio xml:lang="en"><p>Kudryavtsev Igor V. - PhD (Biology), Senior Research Associate, Department of Immunology, IEM; Associate Professor, Department of Immunology, First St.PSI. Pavlov MU.</p><p>197376, St. Petersburg, Acad. Pavlov str., 12, Phone: 7(812) 234-16-69</p></bio><email xlink:type="simple">igorek1981@yandex.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мошев</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Moshev</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мошев Антон Викторович — младший научный сотрудник лаборатории клеточно-молекулярной физиологии и патологии.</p><p>Красноярск</p></bio><bio xml:lang="en"><p>Moshev Anton Viktorovich - Junior Research Associate, Laboratory of Molecular and Cellular Physiology and Pathology.</p><p>Krasnoyarsk</p></bio><email xlink:type="simple">kinger1@mail2000.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБНУ «Федеральный исследовательский центр „Красноярский научный центр Сибирского отделения Российской академии наук“», обособленное подразделение Научно-исследовательский институт медицинских проблем Севера</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Institute of Medical Problems of the North, Krasnoyarsk Science Center, Siberian Branch, Russian Academy of Sciences</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФРБНУ Институт экспериментальной медицины; ФГБОУВО «Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова» Министерства здравоохранения РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Institute of Experimental Medicine; First St. Petersburg State I. Pavlov Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>14</day><month>04</month><year>2020</year></pub-date><volume>22</volume><issue>2</issue><fpage>347</fpage><lpage>356</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Савченко А.А., Борисов А.Г., Кудрявцев И.В., Мошев А.В., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Савченко А.А., Борисов А.Г., Кудрявцев И.В., Мошев А.В.</copyright-holder><copyright-holder xml:lang="en">Savchenko A.A., Borisov A.G., Kudryavtsev I.V., Moshev A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/1890">https://www.mimmun.ru/mimmun/article/view/1890</self-uri><abstract><p>Целью данного исследования явилось изучение зависимости фенотипа и активности респираторного взрыва моноцитов от количества Т-регуляторных клеток (Tregs) у больных с раком почки (РП). Больные с РП (T3N0M0, светлоклеточный тип) были обследованы до хирургического лечения. Фенотип Tregs и моноцитов крови изучали методом проточной цитометрии. Исследование состояния респираторного взрыва моноцитов проводилось путем определения активности люцигенин- и люминол-зависимой спонтанной и зимозан-индуцированной хемилюминесценции. Установлено, что количество Tregs в крови больных с РП было увеличено относительно контрольных значений (у пациентов с РП — Me = 6,3%). Все обследованные пациенты были разделены на две группы в соответствии с медианой по Tregs (менее и более 6,3%). Наиболее выраженные изменения в фенотипе моноцитов и их хемилюминесцентной активности были обнаружены у больных с РП с уровнем Tregs менее 6,3%. Только эта группа пациентов имела перераспределение в субпопуляционном составе моноцитов: уменьшение относительного количества классических моноцитов и увеличение относительного содержания неклассических (провоспалительных) моноцитов. Увеличение абсолютного количества общих моноцитов и уменьшение процентного содержания HLA-DR+ и HLA-DR+CD64+ моноцитов было обнаружено у больных РП независимо от количества Tregs в крови. Изменения в фенотипе моноцитов у больных РП сопровождались изменением состояния их респираторного взрыва. Спонтанный синтез супероксид-радикала (первичная активная форм кислорода — АФК) моноцитами у больных РП с низким уровнем Tregs в крови характеризовался более коротким временем активации НАДФН-оксидазы и более высоким уровнем ее активности, чем у пациентов с высоким содержание Tregs в крови. Индекс активации люцигенин-зависимой хемилюминесценции у больных РП был снижен, не зависел от количества Tregs в крови и определялся, по-видимому, недостаточностью метаболических резервов. Спонтанный синтез вторичных АФК в моноцитах у больных РП был снижен и не зависел от количества Tregs в крови. Индуцированный синтез вторичных АФК и индекс активации их синтеза в моноцитах были снижены только у больных РП с пониженным количеством Tregs в крови. В целом характеристики хемилюминесцентной реакции моноцитов у больных РП определяют наличие дисбаланса между синтезом первичного и вторичного АФК в моноцитах крови. Моноциты у больных РП с низким уровнем Tregs в крови характеризуются большей провоспалительной активностью благодаря быстрой активации и интенсивности синтеза первичных АФК.</p></abstract><trans-abstract xml:lang="en"><p>The aim of this work was to reveal the interrelations between the number of T regulatory cells (Tregs) in patients with kidney cancer (KC) and phenotype of peripheral blood monocytes and their capacities to produce ROS. Patients with KC (T3N0M0, clear cell type) were examined prior to surgical treatment. Tregs phenotype and blood monocytes were identified by flow cytometry. ROS production of purified monocytes was carried out through the determination of lucigenin- and luminol-dependent spontaneous and zymosan-induced chemiluminescence activity. It has been found that the relative number of Tregs within total lymphocyte subset in KC patients was increased if compared to control values (in KC patients — Me = 6.3%). Then the patients were divided into two groups according to the median of Tregs number (less and more than 6.3%). The most pronounced changes in the phenotype of monocytes and their chemiluminescent activity were found in KC patients with the Tregs count of less than 6.3%. Our findings suggest that low frequency of Tregs in the periphery was associated with increased relative numbers of “intermediate” and “non-classical” (“pro-inflammatory”) monocytes as it was shown on the samples from patients with KC with a low level of Tregs. According to our data, both groups of KC patients had low levels of HLA-DR expression when comparing to control group. Furthermore, both groups of patients had decreased rates of HLA-DR and CD64 co-expressing cells. Changes in the phenotype of monocytes in patients with KC were closely linked with imbalance in ROS production. Thus, the monocytes spontaneous superoxide radical (primary ROS) synthesis in KC patients with a low Treg numbers were characterized by redused NADPH-oxidase activation time and increased level of its activity if compared to patients with a high Treg rates in peripheral blood. Next, the activation index for lucigenin-dependent chemiluminescence in KC patients was reduced, as well as it was independent of circulating Tregs rates and was determined apparently by the insufficiency of metabolic reserves. Similarly, spontaneous secondary ROS production by the monocytes in KC patients was lower then in healthy controls and was also independent of circulating Tregs rates. Finally, the induced secondary ROS synthesis and activation index for their synthesis in monocytes were reduced only in patients with KC with a low number of Tregs in the blood. In general, the characteristics of the chemiluminescent reaction of monocytes in patients with KC determined the imbalance in peripheral blood monocytes primary and secondary ROS production. Monocytes in patients with KC with a low number of Tregs in the blood were characterized by more pro-inflammatory activity due to the rapid activation and intensity of the synthesis of primary ROS.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>моноциты</kwd><kwd>регуляторные Т-лимфоциты</kwd><kwd>рак почки</kwd><kwd>фенотип</kwd><kwd>хемилюминесцентная активность</kwd><kwd>респираторный взрыв</kwd></kwd-group><kwd-group xml:lang="en"><kwd>monocytes</kwd><kwd>Tregulatory cells</kwd><kwd>kidney cancer</kwd><kwd>phenotype</kwd><kwd>chemiluminescent activity</kwd><kwd>respiratory burst</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Данная работа выполнена при финансовой поддержке Краевого государственного автономного учреждения «Красноярский краевой фонд поддержки научной и научно-технической деятельности» (проект «Механизмы метаболического репрограммирования клеток врожденного иммунитета при опухолевом росте»)</funding-statement><funding-statement xml:lang="en">The study was performed as part of the project «Mechanisms of metabolic reprogramming of the innate immune cells during tumor growth» was funded by Krasnoyarsk Regional Fund of Science</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Akinrinmade O.A., Chetty S., Daramola A.K., Islam M.U., Thepen T., Barth S. CD64: an attractive immunotherapeutic target for m1-type macrophage mediated chronic inflammatory diseases. Biomedicines, 2017, Vol. 5, no. 3, pii: E56. doi: 10.3390/biomedicines5030056.</mixed-citation><mixed-citation xml:lang="en">Akinrinmade O.A., Chetty S., Daramola A.K., Islam M.U., Thepen T., Barth S. CD64: An Attractive Immunotherapeutic Target for M1-type Macrophage Mediated Chronic Inflammatory Diseases. Biomedicines, 2017, Vol. 5, no. 3, pii: E56. doi: 10.3390/biomedicines5030056.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Bharat A., McQuattie-Pimentel A.C., Budinger G.R.S. Non-classical monocytes in tissue injury and cancer. Oncotarget, 2017, Vol. 8, no. 63, pp. 106171-106172.</mixed-citation><mixed-citation xml:lang="en">Bharat A., McQuattie-Pimentel A.C., Budinger G.R.S. Non-classical monocytes in tissue injury and cancer. Oncotarget, 2017, Vol. 8, no. 63, pp. 106171-106172. doi: 10.18632/oncotarget.22584.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Biller J.D., Takahashi L.S. Oxidative stress and fish immune system: phagocytosis and leukocyte respiratory burst activity. An. Acad. Bras. Cienc., 2018, Vol. 90, no. 4, pp. 3403-3414.</mixed-citation><mixed-citation xml:lang="en">Biller J.D., Takahashi L.S. Oxidative stress and fish immune system: phagocytosis and leukocyte respiratory burst activity. An. Acad. Bras. Cienc., 2018, Vol. 90, no. 4, pp. 3403-3414. doi: 10.1590/0001-3765201820170730.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Buscher K., Marcovecchio P., Hedrick C.C., Ley K. Patrolling mechanics of non-classical monocytes in vascular inflammation. Front. Cardiovasc. Med., 2017, Vol. 4, 80. doi: 10.3389/fcvm.2017.00080.</mixed-citation><mixed-citation xml:lang="en">Buscher K., Marcovecchio P., Hedrick C.C., Ley K. Patrolling Mechanics of Non-Classical Monocytes in Vascular Inflammation. Front. Cardiovasc. Med., 2017, Vol. 4, pp. 80. doi: 10.3389/fcvm.2017.00080.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Cranford T.L., Velazquez K.T., Enos R.T., Bader J.E., Carson M.S., Chatzistamou I., Nagarkatti M., Murphy E.A. Loss of monocyte chemoattractant protein-1 expression delays mammary tumorigenesis and reduces localized inflammation in the C3(1)/SV40Tag triple negative breast cancer model. Cancer Biol. Ther., 2017, Vol. 18, no. 2, pp. 85-93.</mixed-citation><mixed-citation xml:lang="en">Cranford T.L., Velázquez K.T., Enos R.T., Bader J.E., Carson M.S., Chatzistamou I., Nagarkatti M., Murphy E.A. Loss of monocyte chemoattractant protein-1 expression delays mammary tumorigenesis and reduces localized inflammation in the C3(1)/SV40Tag triple negative breast cancer model. Cancer Biol. Ther., 2017, Vol. 18, no. 2, pp. 85-93. doi: 10.1080/15384047.2016.1276135.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Fridman WH. From cancer immune surveillance to cancer immunoediting: birth of modern immuno-oncology. J. Immunol., 2018, Vol. 201, no. 3, pp. 825-826.</mixed-citation><mixed-citation xml:lang="en">Fridman W.H. From Cancer Immune Surveillance to Cancer Immunoediting: Birth of Modern Immuno-Oncology. J. Immunol., 2018, Vol. 201, no. 3, pp. 825-826. doi: 10.4049/jimmunol.1800827.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Gordon S. Targeting a monocyte subset to reduce inflammation. Circ. Res., 2012, Vol. 110, no. 12, pp. 1546-1548.</mixed-citation><mixed-citation xml:lang="en">Gordon S. Targeting a monocyte subset to reduce inflammation. Circ. Res., 2012, Vol. 110, no. 12, pp. 1546-1548. doi: 10.1161/RES.0b013e31825ec26d.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Jan H.C., Yang W.H., Ou C.H. Combination of the Preoperative systemic immune-inflammation index and monocyte-lymphocyte ratio as a novel prognostic factor in patients with upper-tract urothelial carcinoma. Ann. Surg. Oncol., 2019, Vol. 26, no. 2, pp. 669-684.</mixed-citation><mixed-citation xml:lang="en">Jan H.C., Yang W.H., Ou C.H. Combination of the Preoperative Systemic Immune-Inflammation Index and Monocyte-Lymphocyte Ratio as a Novel Prognostic Factor in Patients with Upper-Tract Urothelial Carcinoma. Ann. Surg. Oncol., 2019, Vol. 26, no. 2, pp. 669-684. doi: 10.1245/s10434-018-6942-3.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Jones M.B., Alvarez C.A., Johnson J.L., Zhou J.Y., Morris N., Cobb B.A. CD45Rb-low effector T cells require IL-4 to induce IL-10 in FoxP3 Tregs and to protect mice from inflammation. PLoS ONE, 2019, Vol. 14, no. 5, e0216893. doi: 10.1371/journal.pone.0216893</mixed-citation><mixed-citation xml:lang="en">Jones M.B., Alvarez C.A., Johnson J.L., Zhou J.Y., Morris N., Cobb B.A. CD45Rb-low effector T cells require IL-4 to induce IL-10 in FoxP3 Tregs and to protect mice from inflammation. PLoS One, 2019, Vol. 14, no. 5, e0216893. doi: 10.1371/journal.pone.0216893.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Juhas U., Ryba-Stanislawowska M., Brandt-Varma A., Mysliwiec M., Mysliwska J. Monocytes of newly diagnosed juvenile DM1 patients are prone to differentiate into regulatory IL-10(+) M2 macrophages. Immunol. Res., 2019, Vol. 67, no. 1, pp. 58-69.</mixed-citation><mixed-citation xml:lang="en">Juhas U., Ryba-Stanisławowska M., Brandt-Varma A., Myśliwiec M., Myśliwska J. Monocytes of newly diagnosed juvenile DM1 patients are prone to differentiate into regulatory IL-10(+) M2 macrophages. Immunol. Res., 2019, Vol. 67, no. 1, pp. 58-69. doi: 10.1007/s12026-019-09072-0.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Komala A.S., Rachman A. Association of peripheral monocyte count with soluble P-selectin and advanced stages in nasopharyngeal carcinoma. Adv. Hematol., 2018, Vol. 2018, 3864398. doi: 10.1155/2018/3864398.</mixed-citation><mixed-citation xml:lang="en">Komala A.S., Rachman A. Association of Peripheral Monocyte Count with Soluble P-Selectin and Advanced Stages in Nasopharyngeal Carcinoma. Adv. Hematol., 2018, 2018:3864398. doi: 10.1155/2018/3864398.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Komura T., Sakai Y., Harada K., Kawaguchi K., Takabatake H., Kitagawa H., Wada T., Honda M., Ohta T., Nakanuma Y., Kaneko S. Inflammatory features of pancreatic cancer highlighted by monocytes/macrophages and CD4+ T cells with clinical impact. Cancer Sci., 2015, Vol. 106, no. 6, pp. 672-686.</mixed-citation><mixed-citation xml:lang="en">Komura T., Sakai Y., Harada K., Kawaguchi K., Takabatake H., Kitagawa H., Wada T., Honda M., Ohta T., Nakanuma Y., Kaneko S. Inflammatory features of pancreatic cancer highlighted by monocytes/macrophages and CD4+ T cells with clinical impact. Cancer Sci., 2015, Vol. 106, no. 6, pp. 672-686. doi: 10.1111/cas.12663.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kong B.S., Kim Y., Kim G.Y., Hyun J.W, Kim S.H., Jeong A., Kim H.J. Increased frequency of IL-6-producing non-classical monocytes in neuromyelitis optica spectrum disorder. J. Neuroinflammation, 2017, Vol. 14, no. 1, 191. doi: 10.1186/s12974-017-0961-z.</mixed-citation><mixed-citation xml:lang="en">Kong B.S., Kim Y., Kim G.Y., Hyun J.W., Kim S.H., Jeong A., Kim H.J. Increased frequency of IL-6-producing non-classical monocytes in neuromyelitis optica spectrum disorder. J. Neuroinflammation, 2017, Vol. 14, no. 1, pp. 191. doi: 10.1186/s12974-017-0961-z.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kudryavtsev I.V, Subbotovskaya A.I. Application of six-color flow cytometric analysis for immune profile monitoring. Medical Immunology (Russia), 2015, Vol. 17, no. 1, pp. 19-26. doi: 10.15789/1563-0625-2015-1-19-26.</mixed-citation><mixed-citation xml:lang="en">Kudryavtsev I.V., Subbotovskaya A.I. Application of six-color flow cytometric analysis for immune profile monitoring. Medical Immunology, 2015, Vol. 17, no. 1, pp. 19-26. Кудрявцев И.В., Субботовская А.И. Опыт измерения параметров иммунного статуса с использованием шести-цветного цитофлуоримерического анализа // Медицинская иммунология.–2015.–Т. 17, № 1.–С. 19-26. https://doi.org/10.15789/1563-0625-2015-1-19-26</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Li X., Chen Y., Liu X., Zhang J., He X., Teng G., Yu D. Tim3/Gal9 interactions between T cells and monocytes result in an immunosuppressive feedback loop that inhibits Th1 responses in osteosarcoma patients. Int. Immunopharmacol., 2017, Vol. 44, pp. 153-159.</mixed-citation><mixed-citation xml:lang="en">Li X., Chen Y., Liu X., Zhang J., He X., Teng G., Yu D. Tim3/Gal9 interactions between T cells and monocytes result in an immunosuppressive feedback loop that inhibits Th1 responses in osteosarcoma patients. Int. Immunopharmacol., 2017, Vol. 44, pp. 153-159. doi: 10.1016/j.intimp.2017.01.006.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Maecker H., McCoy P., Nussenblatt R. Standardizing immunophenotyping for the human immunology project. Nat. Rev. Immunol., 2012, Vol. 12, pp. 191-200.</mixed-citation><mixed-citation xml:lang="en">Maecker H., McCoy P., Nussenblatt R. Standardizing immunophenotyping for the human immunology project. Nat. Rev. Immunol., 2012, Vol. 12, pp. 191-200. DOI: 10.1038/nri3158.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Mahmoodpoor A., Paknezhad S., Shadvar K., Hamishehkar H., Movassaghpour A.A., Sanaie S., Ghamari A.A., Soleimanpour H. Flow сytometry of CD64, HLA-DR, CD25, and TLRs for diagnosis and prognosis of sepsis in critically Ill patients admitted to the intensive care unit: a review article. Anesth. Pain Med., 2018, Vol. 8, no. 6, e83128. doi: 10.5812/aapm.83128.</mixed-citation><mixed-citation xml:lang="en">Mahmoodpoor A., Paknezhad S., Shadvar K., Hamishehkar H., Movassaghpour A.A., Sanaie S., Ghamari A.A., Soleimanpour H. Flow Cytometry of CD64, HLA-DR, CD25, and TLRs for Diagnosis and Prognosis of Sepsis in Critically Ill Patients Admitted to the Intensive Care Unit: A Review Article. Anesth. Pain Med., 2018, Vol. 8, no. 6, e83128. doi: 10.5812/aapm.83128.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Moreau R., Perianin A., Arroyo V. Review of defective NADPH oxidase activity and myeloperoxidase release in neutrophils from patients with cirrhosis. Front. Immunol., 2019, Vol. 10, 1044. doi: 10.3389/fimmu.2019.01044.</mixed-citation><mixed-citation xml:lang="en">Moreau R., Périanin A., Arroyo V. Review of Defective NADPH Oxidase Activity and Myeloperoxidase Release in Neutrophils From Patients With Cirrhosis. Front. Immunol., 2019, Vol. 10, pp. 1044. doi: 10.3389/fimmu.2019.01044.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Mukherjee R., Kanti Barman P., Kumar Thatoi P., Tripathy R., Kumar Das B., Ravindran B. Non-Classical monocytes display inflammatory features: validation in sepsis and systemic lupus erythematous. Sci. Rep., 2015, Vol. 5, 13886. doi: 10.1038/srep13886.</mixed-citation><mixed-citation xml:lang="en">Mukherjee R., Kanti Barman P., Kumar Thatoi P., Tripathy R., Kumar Das B., Ravindran B. Non-Classical monocytes display inflammatory features: Validation in Sepsis and Systemic Lupus Erythematous. Sci. Rep., 2015, Vol. 5, pp. 13886. doi: 10.1038/srep13886.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Naranjo-Gomez J.S., Castillo J.A., Rojas M., Restrepo B.N., Diaz FJ., Velilla P.A., Castano D. Different phenotypes of non-classical monocytes associated with systemic inflammation, endothelial alteration and hepatic compromise in patients with dengue. Immunology, 2019, Vol. 156, no. 2, pp. 147-163.</mixed-citation><mixed-citation xml:lang="en">Naranjo-Gómez J.S., Castillo J.A., Rojas M., Restrepo B.N., Diaz F.J., Velilla P.A., Castaño D. Different phenotypes of non-classical monocytes associated with systemic inflammation, endothelial alteration and hepatic compromise in patients with dengue. Immunology, 2019, Vol. 156, no. 2, pp. 147-163. doi: 10.1111/imm.13011.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Narasimhan P.B., Marcovecchio P., Hamers A.A.J., Hedrick C.C. Nonclassical monocytes in health and disease. Annu. Rev. Immunol., 2019, Vol. 37, pp. 439-456.</mixed-citation><mixed-citation xml:lang="en">Narasimhan P.B., Marcovecchio P., Hamers A.A.J., Hedrick C.C. Nonclassical Monocytes in Health and Disease. Annu. Rev. Immunol., 2019, Vol. 37, pp. 439-456. doi: 10.1146/annurev-immunol-042617-053119.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">O’Donnell J.S., Teng M.W.L., Smyth M.J. Cancer immunoediting and resistance to T cell-based immunotherapy. Nat. Rev. Clin. Oncol., 2019, Vol. 16, no. 3, pp. 151-167.</mixed-citation><mixed-citation xml:lang="en">O'Donnell J.S., Teng M.W.L., Smyth M.J. Cancer immunoediting and resistance to T cell-based immunotherapy. Nat. Rev. Clin. Oncol., 2019, Vol. 16, no. 3, pp. 151-167. doi: 10.1038/s41571-018-0142-8.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Pence B.D., Yarbro J.R. Classical monocytes maintain ex vivo glycolytic metabolism and early but not later inflammatory responses in older adults. Immun. Ageing, 2019, Vol. 16, 3. doi: 10.1186/s12979-019-0143-1.</mixed-citation><mixed-citation xml:lang="en">Pence B.D., Yarbro J.R. Classical monocytes maintain ex vivo glycolytic metabolism and early but not later inflammatory responses in older adults. Immun. Ageing, 2019, Vol. 16, pp. 3. doi: 10.1186/s12979-019-0143-1.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Pohar J., Simon Q., Fillatreau S. Antigen-specificity in the thymic development and peripheral activity of CD4(+)FOXP3(+) T regulatory cells. Front. Immunol., 2018, Vol. 9, 1701. doi: 10.3389/fimmu.2018.01701.</mixed-citation><mixed-citation xml:lang="en">Pohar J., Simon Q., Fillatreau S. Antigen-Specificity in the Thymic Development and Peripheral Activity of CD4(+)FOXP3(+) T Regulatory Cells. Front. Immunol., 2018, Vol. 9, pp. 1701. doi: 10.3389/fimmu.2018.01701.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Ramello M.C., Tosello Boari J., Canale F.P., Mena H.A., Negrotto S., Gastman B., Gruppi A., Acosta Rodriguez E.V., Montes C.L. Tumor-induced senescent T cells promote the secretion of pro-inflammatory cytokines and angiogenic factors by human monocytes/macrophages through a mechanism that involves Tim-3 and CD40L. Cell Death Dis, 2014, Vol. 5, e1507. doi: 10.1038/cddis.2014.451.</mixed-citation><mixed-citation xml:lang="en">Ramello M.C., Tosello Boari J., Canale F.P., Mena H.A., Negrotto S., Gastman B., Gruppi A., Acosta Rodríguez E.V., Montes C.L. Tumor-induced senescent T cells promote the secretion of pro-inflammatory cytokines and angiogenic factors by human monocytes/macrophages through a mechanism that involves Tim-3 and CD40L. Cell Death Dis., 2014, Vol. 5, e1507. doi: 10.1038/cddis.2014.451.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Romano E., Kusio-Kobialka M., Foukas P.G., Baumgaertner P., Meyer C., Ballabeni P., Michielin O., Weide B., Romero P., Speiser D.E. Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients. Proc. Natl. Acad. Sci. USA, 2015, Vol. 112, no. 19, pp. 6140-6145.</mixed-citation><mixed-citation xml:lang="en">Romano E., Kusio-Kobialka M., Foukas P.G., Baumgaertner P., Meyer C., Ballabeni P., Michielin O., Weide B., Romero P., Speiser D.E. Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients. Proc. Natl. Acad. Sci. USA, 2015, Vol. 112, no. 19, pp. 6140-6145. doi: 10.1073/pnas.1417320112.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Sabir F., Farooq R.K., Asim Ur. Rehman, Ahmed N. Monocyte as an emerging tool for targeted drug delivery: a review. Curr. Pharm. Des., 2018, Vol. 24, no. 44, pp. 5296-5312.</mixed-citation><mixed-citation xml:lang="en">Sabir F., Farooq R.K., Asim Ur. Rehman, Ahmed N. Monocyte as an Emerging Tool for Targeted Drug Delivery: A Review. Curr. Pharm. Des., 2018, Vol. 24, no. 44, pp. 5296-5312. doi: 10.2174/1381612825666190102104642.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Salminen A., Kauppinen A., Kaarniranta K. Myeloid-derived suppressor cells (MDSC): an important partner in cellular/tissue senescence. Biogerontology, 2018, Vol. 19, no. 5, pp. 325-339.</mixed-citation><mixed-citation xml:lang="en">Salminen A., Kauppinen A., Kaarniranta K. Myeloid-derived suppressor cells (MDSC): an important partner in cellular/tissue senescence. Biogerontology, 2018, Vol. 19, no. 5, pp. 325-339. doi: 10.1007/s10522-018-9762-8.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Savchenko A.A., Borisov A.G., Modestov A.A., Moshev A.V., Kudryavtsev I.V., Tonacheva O.G., Koshcheev V.N. Monocytes subpopulations and chemiluminescent activity in patients with renal cell carcinoma. Medical Immunology (Russia), 2015, Vol. 17, no. 2, pp. 141-150. doi: 10.15789/1563-0625-2015-2-141-150.</mixed-citation><mixed-citation xml:lang="en">Savchenko A.A., Borisov A.G., Modestov A.A., Moshev A.V., Kudryavtsev I.V., Tonacheva O.G., Koshcheev V.N. Monocytes subpopulations and chemiluminescent activity in patients with renal cell carcinoma. Medical Immunology, 2015, Vol. 17, no. 2, pp. 141-150. Савченко А.А., Борисов А.Г., Модестов А.А., Мошев А.В., Кудрявцев И.В., Тоначева О.Г., Кощеев В.Н. Фенотипический состав и хемилюминесцентная активность моноцитов у больных почечно-клеточным раком // Медицинская иммунология.2015.Т. 17, № 2.С. 141-150. https://doi.org/10.15789/1563-0625-2015-2-141-150</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Savchenko A.A., Kudryavtsev I.V., Borisov A.G. Methods of estimation and the role of respiratory burst in the pathogenesis of infectious and inflammatory diseases. Russian Journal of Infection and Immunity, 2017, Vol. 7, no. 4, pp. 327-340. doi: 10.15789/2220-7619-2017-4-327-340.</mixed-citation><mixed-citation xml:lang="en">Savchenko A.A., Kudryavtsev I.V., Borisov A.G. Methods of estimation and the role of respiratory burst in the pathogenesis of infectious and inflammatory diseases. Russian Journal of Infection and Immunity, 2017, Vol. 7, no. 4, pp. 327-340. Савченко А.А., Кудрявцев И.В., Борисов А.Г. Методы оценки и роль респираторного взрыва в патогенезе инфекционно-воспалительных заболеваний // Инфекция и иммунитет.2017.Т. 7б № 4.С. 327-340. https://doi.org/10.15789/2220-7619-2017-4-327-340</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Savchenko A.A., Zdzitovetskii D.E., Borisov A.G., Luzan N.A. Chemiluminescent and enzyme activity of neutrophils in patients with widespread purulent peritonitis depending on the outcome of disease. Annals of the Russian Academy of Medical Sciences, 2014, Vol. 69, no. 5-6, pp. 23-28.</mixed-citation><mixed-citation xml:lang="en">Savchenko A.A., Zdzitovetskii D.E., Borisov A.G., Luzan N.A. Chemiluminescent and enzyme activity of neutrophils in patients with widespread purulent peritonitis depending on the outcome of disease. Annals of the Russian academy of medical sciences, 2014, Vol. 69, no. 5-6, pp. 23-28. Савченко А.А., Здзитовецкий Д.Э., Борисов А.Г., Лузан Н.А. Хемилюминесцентная и энзиматическая активность нейтрофильных гранулоцитов у больных распространенным гнойным перитонитом в зависимости от исхода заболевания // Вестник Российской академии медицинских наук.2014.Т. 69, № 5-6.С. 23-28. https://doi.org/10.15690/vramn.v69i5-6.1039</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Schierer S., Ostalecki C., Zinser E., Lamprecht R., Plosnita B., Stich L., Dbrrie J., Lutz M.B., Schuler G., Baur A.S. Extracellular vesicles from mature dendritic cells (DC) differentiate monocytes into immature DC. Life Sci. Alliance, 2018, Vol. 1, no. 6, e201800093. doi: 10.26508/lsa.201800093.</mixed-citation><mixed-citation xml:lang="en">Schierer S., Ostalecki C., Zinser E., Lamprecht R., Plosnita B., Stich L., Dörrie J., Lutz M.B., Schuler G., Baur A.S. Extracellular vesicles from mature dendritic cells (DC) differentiate monocytes into immature DC. Life Sci. Alliance, 2018, Vol. 1, no. 6, e201800093. doi: 10.26508/lsa.201800093.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Shevach E.M. Foxp3(+) T Regulatory cells: still many unanswered questions - a perspective after 20 years of study. Front. Immunol., 2018, Vol. 9, 1048. doi: 10.3389/fimmu.2018.01048.</mixed-citation><mixed-citation xml:lang="en">Shevach E.M. Foxp3(+) T Regulatory Cells: Still Many Unanswered Questions-A Perspective After 20 Years of Study. Front. Immunol., 2018, Vol. 9, pp. 1048. doi: 10.3389/fimmu.2018.01048.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Stansfield B.K., Ingram D.A. Clinical significance of monocyte heterogeneity. Clin. Transl. Med., 2015, Vol. 4, 5. doi: 10.1186/s40169-014-0040-3.</mixed-citation><mixed-citation xml:lang="en">Stansfield B.K., Ingram D.A. Clinical significance of monocyte heterogeneity. Clin. Transl. Med., 2015, Vol. 4, pp. 5. doi: 10.1186/s40169-014-0040-3</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">van de Geer A., Cuadrado E., Slot M.C., van Bruggen R., Amsen D., Kuijpers T.W. Regulatory T cell features in chronic granulomatous disease. Clin. Exp. Immunol., 2019, Vol. 197, no. 2, pp. 222-229.</mixed-citation><mixed-citation xml:lang="en">van de Geer A., Cuadrado E., Slot M.C., van Bruggen R., Amsen D., Kuijpers T.W. Regulatory T cell features in chronic granulomatous disease. Clin. Exp. Immunol., 2019, Vol. 197, no. 2, pp. 222-229. doi: 10.1111/cei.13300.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Wagner M., Koyasu S. Cancer immunoediting by innate lymphoid cells. Trends Immunol., 2019, Vol. 40, no. 5, pp. 415-430.</mixed-citation><mixed-citation xml:lang="en">Wagner M., Koyasu S. Cancer Immunoediting by Innate Lymphoid Cells. Trends Immunol., 2019, Vol. 40, no. 5, pp. 415-430. doi: 10.1016/j.it.2019.03.004.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Wouters K., Gaens K., Bijnen M., Verboven K., Jocken J., Wetzels S., Wijnands E., Hansen D., van Greevenbroek M., Duijvestijn A., Biessen E.A., Blaak E.E., Stehouwer C.D., Schalkwijk C.G. Circulating classical monocytes are associated with CD11c(+) macrophages in human visceral adipose tissue. Sci. Rep., 2017, Vol. 7, 42665. doi: 10.1038/srep42665.</mixed-citation><mixed-citation xml:lang="en">Wouters K., Gaens K., Bijnen M., Verboven K., Jocken J., Wetzels S., Wijnands E., Hansen D., van Greevenbroek M., Duijvestijn A., Biessen E.A., Blaak E.E., Stehouwer C.D., Schalkwijk C.G. Circulating classical monocytes are associated with CD11c(+) macrophages in human visceral adipose tissue. Sci. Rep., 2017, Vol. 7, pp. 42665. doi: 10.1038/srep42665.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Yu C.X., Bai L.Y., Lin J.J., Li S.B., Chen J.Y., He W.J., Yu X.M., Cui X.P., Wang H.L., Chen Y.Z., Zhu L. rhPLD2 inhibits airway inflammation in an asthmatic murine model through induction of stable CD25(+) Foxp3(+) Tregs. Mol. Immunol., 2018, Vol. 101, pp. 539-549.</mixed-citation><mixed-citation xml:lang="en">Yu C.X., Bai L.Y., Lin J.J., Li S.B., Chen J.Y., He W.J., Yu X.M., Cui X.P., Wang H.L., Chen Y.Z., Zhu L. rhPLD2 inhibits airway inflammation in an asthmatic murine model through induction of stable CD25(+) Foxp3(+) Tregs. Mol. Immunol., 2018, Vol. 101, pp. 539-549. doi: 10.1016/j.molimm.2018.07.030.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Zarif J.C., Hernandez J.R., Verdone J.E., Campbell S.P., Drake C.G., Pienta K.J. A phased strategy to differentiate human CD14+ monocytes into classically and alternatively activated macrophages and dendritic cells. Biotechniques, 2016, Vol. 61, no. 1, pp. 33-41.</mixed-citation><mixed-citation xml:lang="en">Zarif J.C., Hernandez J.R., Verdone J.E., Campbell S.P., Drake C.G., Pienta K.J. A phased strategy to differentiate human CD14+monocytes into classically and alternatively activated macrophages and dendritic cells. Biotechniques, 2016, Vol. 61, no. 1, pp. 33-41. doi: 10.2144/000114435.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Zhuang Y., Peng H., Chen Y., Zhou S., Chen Y. Dynamic monitoring of monocyte HLA-DR expression for the diagnosis, prognosis, and prediction of sepsis. Front. Biosci. (Landmark Ed.), 2017, Vol. 22, pp. 1344-1354.</mixed-citation><mixed-citation xml:lang="en">Zhuang Y., Peng H., Chen Y., Zhou S., Chen Y. Dynamic monitoring of monocyte HLA-DR expression for the diagnosis, prognosis, and prediction of sepsis. Front. Biosci. (Landmark Ed), 2017, Vol. 22, pp. 1344-1354. DOI: 10.2741/4547.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
